相似文献
1
Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis.
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):3-4. doi: 10.1111/jdv.17026.
2
Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile.
Expert Opin Pharmacother. 2017 Jan;18(1):115-121. doi: 10.1080/14656566.2016.1269749.
3
Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.
Drugs. 2016 Oct;76(15):1485-1492. doi: 10.1007/s40265-016-0643-7.
4
Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.
Int J Clin Pharmacol Res. 2005;25(4):165-8.
5
The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
Eur J Dermatol. 2009 Nov-Dec;19(6):581-5. doi: 10.1684/ejd.2009.0767. Epub 2009 Sep 2.
6
Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.
J Eur Acad Dermatol Venereol. 2014 May;28 Suppl 2:10-21. doi: 10.1111/jdv.12444.
7
Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review.
Indian J Dermatol Venereol Leprol. 2016 Mar-Apr;82(2):135-44. doi: 10.4103/0378-6323.175919.
8
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
Acta Derm Venereol. 2002;82(2):131-5. doi: 10.1080/00015550252948194.
9
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
Am J Clin Dermatol. 2011 Dec 1;12(6):421-4. doi: 10.2165/11207670-000000000-00000.
10
Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.
Clin Drug Investig. 2015 Apr;35(4):239-45. doi: 10.1007/s40261-015-0269-7.
本文引用的文献
1
Calcipotriol/betamethasone dipropionate foam demonstrates comparable efficacy to clinical trial data in the real world, improves patient satisfaction and is cost-effective.
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1:28-34. doi: 10.1111/jdv.17084.
2
Early efficacy and safety data with fixed-dose combination calcipotriol/betamethasone dipropionate foam attributed to mechanism of absorption and steroid potency.
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):5-9. doi: 10.1111/jdv.17027.
3
Fixed-dose combination calcipotriol/betamethasone dipropionate foam provides a rapid onset of action, effective itch relief and improves patient quality of life.
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):20-27. doi: 10.1111/jdv.17085.
4
Efficacy and safety of fixed-dose combination calcipotriol/betamethasone dipropionate foam for the treatment of psoriasis.
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1:10-19. doi: 10.1111/jdv.17028.
5
Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis.
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):35-41. doi: 10.1111/jdv.17053.
6
Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study.
J Eur Acad Dermatol Venereol. 2017 Jan;31(1):119-126. doi: 10.1111/jdv.13859. Epub 2016 Aug 17.
7
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.
J Dermatolog Treat. 2016;27(2):120-7. doi: 10.3109/09546634.2015.1083935. Epub 2015 Oct 7.
8
Compatibility of calcipotriene with other topical medications.
J Am Acad Dermatol. 1998 Jun;38(6 Pt 1):1010-1. doi: 10.1016/s0190-9622(98)70171-9.
9
A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.
J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):268-9. doi: 10.1016/s0190-9622(96)90349-7.
10
Betamethasone dipropionate in optimized vehicle. Intermittent pulse dosing for extended maintenance treatment of psoriasis.
Arch Dermatol. 1987 Oct;123(10):1308-11. doi: 10.1001/archderm.123.10.1308.
Zotero 插件